ARQQ Form 144: Insider Plans to Sell 811 Shares ($34,963)

Insider sale notice for ARQQ: The Form 144 shows a proposed sale of 811 common shares of Arqit Quantum Inc. (to be executed through Fidelity Brokerage Services) with an aggregate market value of $34,963.02 and an approximate sale date of 10/02/2025.

Rhea-AI Filing Summary

Insider sale notice for ARQQ: The Form 144 shows a proposed sale of 811 common shares of Arqit Quantum Inc. (to be executed through Fidelity Brokerage Services) with an aggregate market value of $34,963.02 and an approximate sale date of 10/02/2025. Those 811 shares were acquired by the filer on 10/01/2025 through restricted stock vesting as compensation and payment was recorded on the same date. The filing also discloses prior small sales by the same person in the past three months: 238 shares sold for $8,151.83 on 07/02/2025 and 3 shares sold for $84.99 on 09/03/2025. The filer certifies they are not aware of any undisclosed material adverse information about the issuer.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the ARQQ Form 144 filed notice report?

It reports a proposed sale of 811 common shares of Arqit Quantum Inc. with an aggregate market value of $34,963.02, to be sold approximately on 10/02/2025 through Fidelity Brokerage Services.

How were the 811 ARQQ shares acquired?

The 811 shares were acquired on 10/01/2025 via restricted stock vesting from the issuer and recorded as compensation.

Has the filer sold ARQQ shares recently?

Yes. The filer sold 238 shares for $8,151.83 on 07/02/2025 and 3 shares for $84.99 on 09/03/2025.

Which broker will handle the proposed ARQQ sale?

The proposed sale is listed with Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield, RI.

Does the filer claim any undisclosed material information about ARQQ?

By signing the notice, the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/02/2025 - 03:43 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001967066
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Arqit Quantum Inc.
SEC File Number	001-40777
Address of Issuer	3 ORCHARD PLACE LONDON UNITED KINGDOM SW1H 0BF
Phone	44 203 91 70155
Name of Person for Whose Account the Securities are To Be Sold	Shiu Daniel
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	811	34963.02	11545354	10/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/01/2025	Restricted Stock Vesting	Issuer			811	10/01/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Daniel Shiu 3 Orchard Place London X0 SW1H 0BF	Common	07/02/2025	238	8151.83
Daniel Shiu 3 Orchard Place London X0 SW1H 0BF	Common	09/03/2025	3	84.99

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	10/02/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jared Cook, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Daniel Shiu
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)